Toxicology — Cyanide Poisoning

• Cytochrome c oxidase inhibition (primary mechanism): Cyanide binds with extraordinarily high affinity (Kd ~10⁻¹⁵ M) to the ferric iron (Fe³⁺) in the heme a₃ cytochrome of cytochrome c oxidase (Complex IV), the terminal electron acceptor in the mitochondrial electron transport chain. This binding is essentially irreversible in the physiologic timeframe. By blocking electron transfer to oxygen, cyanide prevents the generation of the proton gradient necessary for ATP synthesis via oxidative phosphorylation. Even in the presence of abundant oxygen saturation in arterial blood, cells cannot utilize it—hence the clinical hallmark of histotoxic hypoxia rather than hypoxemic hypoxia. The brain and heart, with the highest oxygen consumption rates and greatest dependence on aerobic ATP production, are most vulnerable. Neurons typically require 3-5 minutes of uninterrupted aerobic metabolism; irreversible neuronal necrosis begins after 3-4 minutes of complete cyanide blockade.

• Cellular energy depletion and metabolic acidosis: Once oxidative phosphorylation ceases, cells become dependent on anaerobic glycolysis, which produces only 2 ATP per glucose versus ~30 ATP from aerobic metabolism. This catastrophic energy deficit rapidly depletes ATP and other high-energy phosphate pools. Anaerobic metabolism generates excess lactate, driving profound metabolic acidosis (often with normal or near-normal PaO₂ and normal oxygen saturation, a critical diagnostic clue). The acidosis is accompanied by increased anion gap. Intracellular calcium homeostasis fails as ATP-dependent Na⁺/K⁺-ATPase pumps and Ca²⁺-ATPase pumps cease functioning, leading to intracellular calcium accumulation, activation of proteases and endonucleases, and initiation of apoptotic and necrotic pathways.

• Secondary tissue damage from reperfusion and free radicals: After cyanide exposure ends (either spontaneously cleared or treated), restoration of aerobic metabolism triggers rapid generation of reactive oxygen species (ROS) as the electron transport chain resumes. This paradoxical reperfusion injury can exacerbate cellular damage, particularly in the central nervous system. Additionally, the acute energy depletion in excitatory neurons causes excessive glutamate release, which activates N-methyl-D-aspartate (NMDA) receptors, amplifying calcium influx and excitotoxic injury.

• Secondary effects from toxin metabolism: Small amounts of cyanide undergo hepatic metabolism via rhodanese (thiosulfate sulfurtransferase) to form the relatively nontoxic thiocyanate (SCN⁻). Rhodanese requires thiosulfate (S₂O₃²⁻) as a sulfur donor; this endogenous pathway is slow and limited by available thiosulfate. The metabolic rate is insufficient to prevent toxicity during acute poisoning but becomes relevant during chronic low-level exposure or as part of treatment.

• Differential organ system effects: The cardiovascular system experiences direct myocardial depression from energy depletion, compounded by severe metabolic acidosis causing dysrhythmias. Pulmonary effects include pulmonary edema (both cardiogenic from myocardial failure and noncardiogenic from direct lung toxicity). The gastrointestinal tract may release cyanide from ingested salts, and the acidotic environment can increase cyanide's ability to cross membranes. The respiratory center in the medulla is exquisitely sensitive to cyanide; respiratory drive becomes depressed despite hypoxic stimulus, paradoxically causing hypoventilation in a hypoxic patient.

• Industrial and occupational exposures: Workers in metal plating facilities, mining operations, chemical manufacturing plants, jewelry production, and photography (where cyanide salts are used in blueprint development) face the greatest occupational risk. Accidental inhalation of hydrogen cyanide gas or skin absorption of cyanide salts can occur with inadequate ventilation or personal protective equipment. Fire fighters responding to structure fires face exposure to hydrogen cyanide produced by combustion of nitrogen-containing polymers (plastics, polyurethane, silk, wool) at temperatures >200°C; this is thought to account for significant morbidity/mortality in fire casualties beyond that from carbon monoxide alone.

• Criminal/intentional exposures: Cyanide salts or solutions may be used in suicide attempts (ingestion of potassium or sodium cyanide salts) or criminal poisoning. The substance gained notoriety in historical cases (e.g., Tylenol tampering scare in 1982, though never successfully deployed) and potential bioterrorism scenarios, though actual incidents remain exceedingly rare in developed nations.

• Pharmaceutical and medical exposures: Sodium nitroprusside, a potent parenteral vasodilator used for hypertensive emergency and cardiac afterload reduction, metabolizes to release cyanide as a byproduct. Patients receiving prolonged infusions (especially >4 μg/kg/min or >72 hours total) risk cyanide accumulation and toxicity. This represents the most common medically-acquired form of cyanide poisoning in hospitals. Additionally, nitrile gloves can degrade and release small amounts of cyanide if exposed to specific solvents, though clinical toxicity from this source is not established.

• Dietary and accidental sources: Cassava plants, lima beans, and kernels of apricots, peaches, and almonds contain cyanogenic glycosides (e.g., amygdalin) that release cyanide when metabolized. Large ingestions of these foods are theoretically toxic but rarely cause clinical poisoning due to the quantities required. Accidental ingestion of industrial cyanide salts (mistaken for cooking ingredients) causes acute poisoning.

• Risk factors for severity: Exposure route (inhalation fastest, ingestion slower but still very rapid), concentration/amount exposed, duration of exposure, temperature (elevated temperature increases volatility of hydrogen cyanide gas), and pre-existing cardiopulmonary or metabolic disease all modify risk. Patients with reduced rhodanese activity (genetic variants, though uncommon) may be at slightly higher risk, as might those with sulfur deficiency, though this is rarely clinically relevant in acute poisoning.

• Rapid onset of altered mental status and loss of consciousness: Within seconds to minutes of high-dose exposure (especially inhalational or IV), patients develop acute confusion, agitation, or impaired consciousness progressing to coma. The mechanism combines direct toxicity to the central nervous system (brain uses ~20% of total body oxygen, requiring maximal ATP production) and severe metabolic acidosis. This rapid CNS penetration distinguishes cyanide from many other toxins and should raise suspicion for cyanide in any patient with sudden unexplained altered mental status in a high-risk setting.

• Severe dyspnea and respiratory distress: Paradoxically, despite adequate or elevated oxygen delivery, patients develop tachypnea and dyspnea driven by metabolic acidosis stimulating the respiratory center. However, with severe poisoning, respiratory depression ensues as the medullary respiratory center itself becomes energy-depleted and fails. This creates the critical trap: a patient may be hypoxic because they cannot breathe, not because oxygen is unavailable—a distinction lost if clinical assessment is limited to pulse oximetry (which may be normal) rather than arterial blood gas analysis.

• Cardiovascular collapse and dysrhythmias: Hypotension, bradycardia, and conduction abnormalities develop within minutes as the heart's metabolic demands exceed its cyanide-impaired ATP supply. Myocardial irritability increases, predisposing to ventricular fibrillation or asystole. Severe metabolic acidosis exacerbates dysrhythmia risk. In some cases, an initial sympathetic surge (catecholamine release from hypoxia-stressed adrenal medulla) causes tachycardia and hypertension briefly before cardiovascular collapse ensues.

• Seizures and muscular rigidity: Generalized tonic-clonic seizures occur in 10-15% of cyanide poisoning cases, reflecting severe CNS energy depletion and excitotoxicity. Alternatively, muscle rigidity or opisthotonus may occur from direct CNS involvement and loss of coordinated motor control.

• "Healthy" appearance with profound pathophysiology: A deceptively benign clinical appearance is characteristic—patients may have normal or pink skin coloration (unlike the cyanosis seen in hypoxemic hypoxia) because venous blood remains well-oxygenated (oxygen is not being utilized). The arterio-venous oxygen difference is low, not high as in typical shock. Pulse oximetry typically reads normal or near-normal, creating a dangerous false sense of security: "How can this patient in cardiac arrest have normal oxygen saturation?" The answer is cyanide-induced histotoxic hypoxia.

• Pulmonary edema: Acute pulmonary edema with frothy, sometimes blood-tinged sputum may develop from acute left ventricular failure and/or direct cytotoxic effects on pulmonary capillary endothelium. This can occur even with "normal" neck veins if the edema develops rapidly before systemic venous hypertension manifests.

• Physical examination findings: Beyond altered mental status and cardiopulmonary instability, examination may reveal dilated pupils (fixed and dilated pupils develop late, indicating severe brain injury), pink or flushed skin (preserved oxygenation of peripheral tissues), bradycardia with hypotension, and absent or severely depressed reflexes if seizure activity occurs. Agonal respirations may be present if respiratory center depression is severe.

• Clinical variants by exposure route and timing:
• Inhalational/IV: Most rapid, minutes to cardiac arrest
• Ingestion: Slightly slower (5-30 minutes depending on amount/gastric contents) but still catastrophically rapid
• Chronic low-level exposure: Thyroid dysfunction, neuropathy, and metabolic encephalopathy (rare in modern occupational settings)

• Clinical diagnosis and history: Recognition requires awareness of exposure context. Key historical features include: (1) occupational/industrial setting exposure or fire exposure; (2) sodium nitroprusside infusion in ICU patient; (3) ingestion of unknown substance with rapid onset of cardiovascular collapse; (4) cluster of similar presentations (suggesting environmental exposure). The classic triad is rapid loss of consciousness, severe metabolic acidosis, and normal or near-normal pulse oximetry with profound shock—this constellation is virtually pathognomonic.

• Arterial blood gas analysis (ABG)—most important initial test: ABG reveals severe metabolic acidosis (pH <7.20, bicarbonate <15 mEq/L) with elevated anion gap (typically 20-30 or higher). Critically, PaO₂ is normal or elevated (usually >80-100 mmHg) while the patient is in shock or dying—this is the diagnostic hallmark. Standard pulse oximetry reads normal (SpO₂ 95-100%) despite severe tissue hypoxia. Venous blood gas also shows acidosis. The lactate level is typically markedly elevated (often >5 mmol/L, sometimes >20 mmol/L) due to anaerobic metabolism; this lactate-driven anion gap metabolic acidosis with normal PaO₂ is highly suspicious.

• Blood cyanide levels: Laboratory confirmation via plasma cyanide concentration is definitive but delayed (results return hours later from toxicology labs). Normal levels are <1 μmol/L; levels >3-4 μmol/L are consistent with toxicity; >20 μmol/L often fatal. These results confirm poisoning post-hoc and cannot guide acute treatment decisions. Some forensic labs can quantify cyanide rapidly, but most hospitals lack this capability.

• Carboxyhemoglobin and methemoglobin levels: These are normal in pure cyanide poisoning and can help exclude carbon monoxide poisoning (which presents similarly) when confirmed absent.

• Other laboratory findings:
• Elevated lactate (as noted) is sensitive but nonspecific
• Thiocyanate levels can be measured but only indicate chronic exposure; acute levels are not clinically useful
• Metabolic panel: hyperkalemia may develop from cellular lysis; renal function may decline from shock
• Troponin/CK: may be elevated from myocardial and skeletal muscle necrosis

• Imaging findings: Chest X-ray may show pulmonary edema pattern (bilateral infiltrates). Head CT is typically normal acutely but may show edema/basal ganglia involvement in survivors with delayed neurologic sequelae. Imaging is not diagnostically specific and should not delay treatment.

• Diagnostic criteria and scoring: No formal diagnostic scoring system exists for cyanide poisoning. Diagnosis relies on clinical-toxicological suspicion: unexplained rapid cardiovascular collapse in appropriate context + severe metabolic acidosis + normal PaO₂ = strong presumptive diagnosis warranting immediate empiric antidote therapy.

• Differential diagnosis considerations:
• Carbon monoxide (CO) poisoning: Similar presentation (altered mental status, cardiac collapse, acidosis) but carboxyhemoglobin (COHb) is elevated; cherry-red lips may occur (cyanide patients have normal or pink appearance)
• Acute coronary syndrome/myocardial infarction: Rapid cardiac collapse, but ECG changes and troponin evolution differ
• Pulmonary embolism: Dyspnea and hypotension but less severe metabolic acidosis and no exposure history
• Septic shock: Metabolic acidosis present but develops over hours; no acute exposure history
• Hydrogen sulfide poisoning: Similar rapid presentation but "rotten egg" smell and different exposure history; can be concurrent with cyanide in certain industrial fires
• Other toxins (organophosphates, sympathomimetics causing hypertensive crisis): Presentation differs by specific toxin

• First-line therapy: Hydroxocobalamin (Vitamin B12a): Hydroxocobalamin is the current gold-standard antidote, FDA-approved since 2006. Mechanism: hydroxocobalamin contains a cobalt center with an open coordination site that irreversibly binds cyanide with extremely high affinity (Kd ~10⁻³⁵ M), forming non-toxic cyanocobalamin (Vitamin B12). This binding is vastly more favorable than cyanide's binding to cytochrome oxidase.
• Dosing: 70 mg/kg IV bolus over 15 minutes for acute symptomatic poisoning (typical adult dose = 5 grams IV for 70 kg adult), can repeat once if needed. Pediatric dosing: 70 mg/kg IV, max 5 grams per dose.
• Advantages: No metabolic byproducts (unlike older agents), effective across multiple exposure routes, minimal side effects, can be given empirically without risk of harm if cyanide poisoning is excluded later.
• Administration logistics: Requires IV access; incompatible with some medications in IV line (flush well); causes harmless red/pink discoloration of urine.
• Efficacy

Complications of the poisoning itself

• Cardiac arrest from ventricular fibrillation/pulseless VT or asystole (immediate emergency): ATP depletion in myocytes plus profound lactic acidosis destabilizes membrane potentials. Signaled by bradycardia and widening QRS preceding arrest. The 2023 AHA Focused Update on cardiac arrest due to poisoning advises giving hydroxocobalamin (with or without sodium thiosulfate) during resuscitation rather than after ROSC.
• Anoxic-histotoxic encephalopathy and delayed parkinsonism: the basal ganglia (globus pallidus, putamen) have the highest oxidative demand and are selectively necrosed; survivors may develop rigidity, bradykinesia, and dystonia days to weeks later, with corresponding hypodensities on delayed CT/MRI. Persistent coma, myoclonus, or new extrapyramidal signs after resuscitation are the warning findings.
• Status epilepticus (emergency): excitotoxic glutamate release with NMDA-mediated calcium influx; benzodiazepines remain first-line.
• Noncardiogenic pulmonary edema/ARDS: direct capillary endothelial injury plus left ventricular failure; frothy sputum with worsening hypoxemia and diffuse infiltrates.
• Rhabdomyolysis with acute kidney injury: seizures, rigidity, and cellular energy failure; suspect with markedly elevated CK, hyperkalemia, and pigmented urine.

Complications of therapy

• Hydroxocobalamin: harmless red discoloration of skin, plasma, and urine, but this chromophore interferes with colorimetric laboratory assays (co-oximetry, bilirubin, creatinine, AST) and can trigger blood-leak alarms that shut down hemodialysis circuits. Transient hypertension and rare anaphylactoid reactions occur.
• Sodium nitrite (emergency risk): deliberately induces methemoglobinemia to scavenge cyanide, but in smoke-inhalation victims with concurrent carboxyhemoglobinemia this can collapse remaining oxygen-carrying capacity. Nitrite also causes vasodilatory hypotension. Excessive methemoglobinemia is signaled by chocolate-brown blood and a saturation gap.
• Sodium thiosulfate / nitroprusside: rhodanese converts cyanide to thiocyanate, which is renally cleared; in renal failure thiocyanate accumulates, producing confusion, psychosis, and seizures.

• **The vignette's smell is *bitter almonds***: the classic olfactory buzzword, though a genetically determined subset of people cannot detect it at all — so its absence never excludes cyanide.
• Normal SpO₂ + normal/high PaO₂ + profound shock and anion-gap lactic acidosis = cyanide until proven otherwise. Pulse oximetry measures hemoglobin saturation, not oxygen utilization; cyanide blocks Complex IV, so oxygen is delivered but unusable.
• Arterialization of venous blood is the single most tested physiologic finding: central venous O₂ saturation is abnormally high and the arteriovenous O₂ difference is narrowed, because tissues extract almost no oxygen.
• Single best next step in a fire victim with soot in the nares, altered mental status, and a markedly elevated lactate: 100% oxygen plus empiric IV hydroxocobalamin. Do not wait for a cyanide level — results return hours later. Treat presumed concurrent carbon monoxide poisoning simultaneously.
• The association examiners love: sodium nitroprusside → cyanide/thiocyanate toxicity, especially with high infusion rates, prolonged duration, or renal insufficiency. Also test-worthy: amygdalin/laetrile from apricot, peach, and bitter almond kernels, and cassava.
• Avoid sodium nitrite in smoke-inhalation victims. Inducing methemoglobinemia on top of carboxyhemoglobinemia strips away remaining oxygen-carrying capacity; hydroxocobalamin (± sodium thiosulfate) is the preferred regimen in fire casualties.
• Common distractors to reject: methylene blue treats methemoglobinemia, not cyanide; hyperbaric oxygen is a carbon monoxide therapy, not a cyanide antidote; activated charcoal binds cyanide poorly and never precedes the antidote; and cherry-red skin is the carbon monoxide buzzword, whereas cyanide patients look pink or unremarkable rather than cyanotic.
• Expect red-orange discoloration of skin and urine after hydroxocobalamin — a benign, expected effect, not an adverse drug reaction. Call Poison Control (1-800-222-1222) in parallel, per standard U.S. practice.